Advertisement

Reactions Weekly

, Volume 1756, Issue 1, pp 200–200 | Cite as

Ipilimumab/nivolumab

C3 glomerulonephritis: case report
Case report
  • 16 Downloads

Reference

  1. George S, et al. CHECKPOINT INHIBITOR (CPI) ASSOCIATED C3 GLOMERULONEPHRITIS (GN). American Journal of Kidney Diseases 73: 736 abstr. 357, No. 5, May 2019. Available from: URL: http://doi.org/10.1053/j.ajkd.2019.03.359 [abstract] - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations